4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0000921895-26-000788
Options or other derivatives
- Director sold 896,800 shares
From the SEC's structured data for this filing
Trades in this filing
Lazar David E. · Director
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-23 | Sale : show line 1 in the form Series AA Convertible Non-Redeemable Preferred Stock | −196,800 | 103,200 | D |
| 2026-03-23 | Sale : show line 2 in the form Series AAA Convertible Non-Redeemable Preferred Stock | −700,000 | 0 | D |
Loading xslF345X06/form412227indp_03232026.xml…